$1,398,025,092
Department of Veterans Affairs·Department of Veterans Affairs
veteransexpired
WORK BEGAN2026-05-01·LATEST ACTION2026-07-01·SOURCEUSASPENDING·SOURCE IDCONT_AWD_36C24026K1008_3600_36W79720D0001_3600
Award description
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
Delivers medications to VA hospitals and clinics serving millions of veterans.
Sub-sectors
va-pharmaceutical-supplyprime-vendor-contracthealthcare-delivery
Why this matters
Ensures steady pharmaceutical supply to 9+ million VA beneficiaries nationwide.
Supply-chain signal
McKESSON's prime vendor status consolidates federal pharmaceutical procurement and supplier competition.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-07-03. Cost: $0.015373.
Period of performance
Start
2026-05-01
End
2026-05-30
Status
expired35 days ago
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_36C24026K1008_3600_36W79720D0001_3600.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.